Follow this preprint
Efficacy and Safety of a Plant-Based Virus-Like Particle Vaccine for COVID-19 Adjuvanted with AS03
Karen Joyce Hager, Gonzalo Pérez Marc, Philipe Gobeil, Ricardo Sobhie Diaz, Gretchen Heizer, Conrado Llapur, Alexander I. Makarkov, Eduardo Vasconcellos, Stephane Pillet, Fernando Riera, Kapil Bhutada, Priscila Geller Wolff, Garry Wallace, Hessam Aazami, Christine E. Jones, Fernando P. Polack, Judith Atkins, Iohann Boulay, Jiwanjeet Dhaliwall, Nathalie Charland, Manon Couture, Julia Jiang-Wright, Nathalie Landry, Sophie Lapointe, Aurélien Lorin, Asif Mahmood, Lawrence H. Moulton, Emmy Pahmer, Julie Parent, Pooja Saxena, Annie Séguin, Luan Tran, Thomas Breuer, Maria Angeles Ceregido, Marguerite Koutsoukos, François Roman, Junya Namba, Marc-André D’Aoust, Sonia Trepanier, Yosuke Kimura, The CoVLP Study Team, Brian J. Ward
doi: https://doi.org/10.1101/2022.01.17.22269242
Now published in New England Journal of Medicine doi: 10.1056/NEJMoa2201300
Karen Joyce Hager
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Gonzalo Pérez Marc
2Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Av. Luis Maria Campos 726, Buenos Aires Buenos Aires C1426, Argentina
Philipe Gobeil
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Ricardo Sobhie Diaz
3Infectious Diseases Division, Paulista School of Medicine, Federal University of Sao Paulo, Brazil, and Azidus Brasil Pesquisa e Desenvolvimento Ltda, Valinhos São Paulo 13271-130, Brazil
Gretchen Heizer
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Conrado Llapur
4Clinica Mayo de UMCB SRL, Combate de San Lorenzo 449, San Miguel de Tucumán Tucumán T4000, Argentina
Alexander I. Makarkov
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Eduardo Vasconcellos
5Instituto de Pesquisas Clinicas L2IP, SGAS 613 - lote 95 - Bloco A, Sala 6, Ed. L2 Complexo Médico Hospitalar, DF 70200-730, Brazil
Stephane Pillet
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Fernando Riera
6Sanatorio Allende, Av. Hipolito Yrigoyen 384, Cordoba, Cordoba 5000, Argentina
Kapil Bhutada
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Priscila Geller Wolff
7IBPClin Instituto Brasil de Pequisa Clinica, R. Da Gloria, 344 – Gloria, Rio de Janeiro RJ 20241-180, Brazil
Garry Wallace
8Dawson Clinical Research Inc., 83 Dawson Road, Guelph, Ontario N1H 1B1, Canada
Hessam Aazami
9Hope Clinical, 22030 Sherman Way, Canoga Park, California 91303, United States
Christine E. Jones
10Clinical and Experimental Sciences, University of Southampton and NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, SO16 6YD, United Kingdom
Fernando P. Polack
11Fundacion INFANT, Gavilán 15, Buenos Aires, Argentina
Judith Atkins
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Iohann Boulay
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Jiwanjeet Dhaliwall
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Nathalie Charland
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Manon Couture
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Julia Jiang-Wright
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Nathalie Landry
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Sophie Lapointe
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Aurélien Lorin
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Asif Mahmood
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Lawrence H. Moulton
12Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD 21217, USA
Emmy Pahmer
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Julie Parent
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Pooja Saxena
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Annie Séguin
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Luan Tran
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Thomas Breuer
13GlaxoSmithKline Vaccines, Wavre, Belgium
Maria Angeles Ceregido
13GlaxoSmithKline Vaccines, Wavre, Belgium
Marguerite Koutsoukos
13GlaxoSmithKline Vaccines, Wavre, Belgium
François Roman
13GlaxoSmithKline Vaccines, Wavre, Belgium
Junya Namba
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Marc-André D’Aoust
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Sonia Trepanier
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Yosuke Kimura
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
Brian J. Ward
1Medicago Inc., 1020 route de l’Église, Bureau 600, Québec, QC, Canada, G1V 3V9
14Research Institute of the McGill University Health Center, 1001 Decarie St, Montréal, QC, Canada H4A 3J1
Posted January 26, 2022.
Efficacy and Safety of a Plant-Based Virus-Like Particle Vaccine for COVID-19 Adjuvanted with AS03
Karen Joyce Hager, Gonzalo Pérez Marc, Philipe Gobeil, Ricardo Sobhie Diaz, Gretchen Heizer, Conrado Llapur, Alexander I. Makarkov, Eduardo Vasconcellos, Stephane Pillet, Fernando Riera, Kapil Bhutada, Priscila Geller Wolff, Garry Wallace, Hessam Aazami, Christine E. Jones, Fernando P. Polack, Judith Atkins, Iohann Boulay, Jiwanjeet Dhaliwall, Nathalie Charland, Manon Couture, Julia Jiang-Wright, Nathalie Landry, Sophie Lapointe, Aurélien Lorin, Asif Mahmood, Lawrence H. Moulton, Emmy Pahmer, Julie Parent, Pooja Saxena, Annie Séguin, Luan Tran, Thomas Breuer, Maria Angeles Ceregido, Marguerite Koutsoukos, François Roman, Junya Namba, Marc-André D’Aoust, Sonia Trepanier, Yosuke Kimura, The CoVLP Study Team, Brian J. Ward
medRxiv 2022.01.17.22269242; doi: https://doi.org/10.1101/2022.01.17.22269242
Now published in New England Journal of Medicine doi: 10.1056/NEJMoa2201300
Subject Area
Reviews and Context
1
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
5
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (420)
- Allergy and Immunology (745)
- Anesthesia (217)
- Cardiovascular Medicine (3208)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13212)
- Forensic Medicine (19)
- Gastroenterology (887)
- Genetic and Genomic Medicine (5043)
- Geriatric Medicine (469)
- Health Economics (771)
- Health Informatics (3168)
- Health Policy (1122)
- Hematology (419)
- HIV/AIDS (997)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4784)
- Nursing (253)
- Nutrition (708)
- Oncology (2464)
- Ophthalmology (698)
- Orthopedics (277)
- Otolaryngology (336)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1272)
- Primary Care Research (546)
- Public and Global Health (7344)
- Radiology and Imaging (1663)
- Respiratory Medicine (963)
- Rheumatology (471)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (227)
- Urology (199)